Načítá se...
Treatment of Myelofibrosis: Old and New Strategies
Myelofibrosis (MF) is a BCR-ABL1–negative myeloproliferative neoplasm that is mainly characterised by reactive bone marrow fibrosis, extramedullary haematopoiesis, anaemia, hepatosplenomegaly, constitutional symptoms, leukaemic progression, and shortened survival. As such, this malignancy is still o...
Uloženo v:
| Vydáno v: | Clin Med Insights Blood Disord |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5428134/ https://ncbi.nlm.nih.gov/pubmed/28579852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179545X17695233 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|